Anteprima
Vedrai una selezione di 20 pagine su 127
Appunti Anatomia patologica (Anatomical Pathology, Biomolecular Basis of Anatomical Pathology) Pag. 1 Appunti Anatomia patologica (Anatomical Pathology, Biomolecular Basis of Anatomical Pathology) Pag. 2
Anteprima di 20 pagg. su 127.
Scarica il documento per vederlo tutto.
Appunti Anatomia patologica (Anatomical Pathology, Biomolecular Basis of Anatomical Pathology) Pag. 6
Anteprima di 20 pagg. su 127.
Scarica il documento per vederlo tutto.
Appunti Anatomia patologica (Anatomical Pathology, Biomolecular Basis of Anatomical Pathology) Pag. 11
Anteprima di 20 pagg. su 127.
Scarica il documento per vederlo tutto.
Appunti Anatomia patologica (Anatomical Pathology, Biomolecular Basis of Anatomical Pathology) Pag. 16
Anteprima di 20 pagg. su 127.
Scarica il documento per vederlo tutto.
Appunti Anatomia patologica (Anatomical Pathology, Biomolecular Basis of Anatomical Pathology) Pag. 21
Anteprima di 20 pagg. su 127.
Scarica il documento per vederlo tutto.
Appunti Anatomia patologica (Anatomical Pathology, Biomolecular Basis of Anatomical Pathology) Pag. 26
Anteprima di 20 pagg. su 127.
Scarica il documento per vederlo tutto.
Appunti Anatomia patologica (Anatomical Pathology, Biomolecular Basis of Anatomical Pathology) Pag. 31
Anteprima di 20 pagg. su 127.
Scarica il documento per vederlo tutto.
Appunti Anatomia patologica (Anatomical Pathology, Biomolecular Basis of Anatomical Pathology) Pag. 36
Anteprima di 20 pagg. su 127.
Scarica il documento per vederlo tutto.
Appunti Anatomia patologica (Anatomical Pathology, Biomolecular Basis of Anatomical Pathology) Pag. 41
Anteprima di 20 pagg. su 127.
Scarica il documento per vederlo tutto.
Appunti Anatomia patologica (Anatomical Pathology, Biomolecular Basis of Anatomical Pathology) Pag. 46
Anteprima di 20 pagg. su 127.
Scarica il documento per vederlo tutto.
Appunti Anatomia patologica (Anatomical Pathology, Biomolecular Basis of Anatomical Pathology) Pag. 51
Anteprima di 20 pagg. su 127.
Scarica il documento per vederlo tutto.
Appunti Anatomia patologica (Anatomical Pathology, Biomolecular Basis of Anatomical Pathology) Pag. 56
Anteprima di 20 pagg. su 127.
Scarica il documento per vederlo tutto.
Appunti Anatomia patologica (Anatomical Pathology, Biomolecular Basis of Anatomical Pathology) Pag. 61
Anteprima di 20 pagg. su 127.
Scarica il documento per vederlo tutto.
Appunti Anatomia patologica (Anatomical Pathology, Biomolecular Basis of Anatomical Pathology) Pag. 66
Anteprima di 20 pagg. su 127.
Scarica il documento per vederlo tutto.
Appunti Anatomia patologica (Anatomical Pathology, Biomolecular Basis of Anatomical Pathology) Pag. 71
Anteprima di 20 pagg. su 127.
Scarica il documento per vederlo tutto.
Appunti Anatomia patologica (Anatomical Pathology, Biomolecular Basis of Anatomical Pathology) Pag. 76
Anteprima di 20 pagg. su 127.
Scarica il documento per vederlo tutto.
Appunti Anatomia patologica (Anatomical Pathology, Biomolecular Basis of Anatomical Pathology) Pag. 81
Anteprima di 20 pagg. su 127.
Scarica il documento per vederlo tutto.
Appunti Anatomia patologica (Anatomical Pathology, Biomolecular Basis of Anatomical Pathology) Pag. 86
Anteprima di 20 pagg. su 127.
Scarica il documento per vederlo tutto.
Appunti Anatomia patologica (Anatomical Pathology, Biomolecular Basis of Anatomical Pathology) Pag. 91
1 su 127
D/illustrazione/soddisfatti o rimborsati
Disdici quando
vuoi
Acquista con carta
o PayPal
Scarica i documenti
tutte le volte che vuoi
Estratto del documento

Neoplasia and Tumor Classification

FAPo MENo neurofibromatosis type 1 and 2o Von Hippel-Lindau syndromeo➢ →familial cancers but role of inherited predisposition may not be clear in an individual casecolon/ovarian/breasto➢ autosomal recessive syndromes of defective DNA repairBRCA1/BRCA2o →certain forms of benign neoplasia also constitute pre-cancerous conditions, e.g. villous adenoma of colonit increases in size develops cancerous changes in up to 50% casesneoplasia➔ parenchyma: neoplastic cells➔ supportive stroma: connective tissue and blood vessels from hostbenign neoplasia➢ epithelial: classified based on gross morphology andmicroscopic architecture• benign epithelial tumors➔ adenoma➔ papilloma➔ cystadenoma➔ papillarypolypo➢ mesenchymal: attach suffix -oma to the cell of originand are classified depending on the original cell• mesenchymal benign tumors➔ leiomyoma➔ lipoma➔ rhabdomyoma➔ schwannoma➔ fibromamalignant tumors➢ carcinoma: malignant epithelial cell origin,

derivedfrom any of the three germ layers(ectodermal/mesodermal/endodermal) ➢ sarcoma: malignant tumors arising in mesenchymaltissue because they have little connective tissue stromaand so are fleshymalignant epithelial tumors ➢ adenocarcinoma: glandular growth pattern ismicroscopically recognizablemalignant tumor derived form epithelial cellso with functions related to synthesis orabsorption ➢ squamous carcinoma: squamous cell deriving fromany multilayered flat epitheliummalignant tumor deriving from epithelialo cells in which the main function is related tocovering functions (epidermal/mucosalepithelial cells in the mouth) →undifferentiated malignant tumors: not possible toidentify origin cell + sometimes it is impossible to make thedifferential diagnosis between carcinoma and sarcoma →mixed tumor: divergent differentiation of a single line of parenchymal cells creates what are called mixedtumors →teratoma: variety of parenchymal cell types representative of more than one germ layer

one germ layer, totipotential cell, usually all three (principally encountered in the gonads) → choristoma rest of normal tissue included in another tissue → hamartoma aberrant differentiation of disorganized mature cells (lung hamartoma contains islands of cartilage, blood vessels, bronchial-type structures and lymphoid tissue)

differences between benign and malignant tumors → differentiation = extent to which parenchymal cells resemble comparable normal cells, morphologically and functionally

benign tumors are constituted by well differentiated cells which maintain their normal relationship with other cells, maintain an organization like the normal tissue from which they derive + maintain power in control of proliferation (tumor limited in a certain area) → malignant tumors range from well differentiated to undifferentiated, no control of proliferation (increased proliferation and step-by-step loss of differentiation) leading to anaplasia + metastasis

→ anaplasia:

malignant neoplasms composed of undifferentiated cells are said to be anaplastic. Anaplasia is a lack of differentiation and is considered a hallmark of malignant transformation. It is marked by a number of morphological and functional changes. Cytology: - Pleomorphism: variation in size and shape (we can have giant cells together with small cells) - Hyperchromatic nuclei: more stained - High nucleus/cytoplasm ratio: when we have undifferentiated tumors, the cells go back resembling stem cells. They are characterized by big nuclei, with dispersed euchromatin, and less cytoplasm - Prominent nucleoli - Large number of mitoses - Atypical and bizarre mitoses - Tumor giant cells Histology: - Disturbed orientation - Loss of adhesiveness: e.g. presence/absence of E-cadherin in breast cancer - In differentiated cells, we have the presence of great amounts of heterochromatin representing not-functioning DNA - Necrosis: not enough information providedblood supply to neoplastic cells (need to have lots of metabolites) hence the core of malignant neoplasm becomes necrotic; malignant tumors are characterized by hemorrhagic aspect because we have new formation of blood vessels and necrosis
  1. dystrophic calcification due to abnormal function of malignant neoplastic cells, e.g. calcification in one type of thyroid carcinoma (papillomatous carcinoma) characterized by follicles containing formation of multiple layers of calcification
➔ dysplasia: epithelial disordered growth, loss in the uniformity of the individual cells as well as loss in their architectural orientation → cells exhibit considerable pleomorphisms and deeply stained nuclei mitotic figures are more abundant although almost invariably they conform to normal pattern (sometimes they appear in abnormal location within the epithelium) dysplasia starts from the basal layer (mild dysplasia), then when we can have a moderate dysplasia when cells are located in the middle
  1. layer and we have a severe dysplasia when all layers of the epidermal tissue are involved
  2. when dysplastic changes are marked (= severe dysplasia) and involve the entire thickness of the epithelium, the lesion is considered a pre-invasion neoplasm and it is referred to as carcinoma in situ

Rate of growth: most benign tumors grow slowly over a period of years, whereas most cancers grow rapidly, sometimes at an erratic pace and eventually spread and kill their hosts. In general, the growth rate of tumors correlates with their level of differentiation and thus most malignant tumors grow rapidly compared to benign lesions.

Local invasion: nearly all benign tumors grow as cohesive expansile masses that remain localized to their site of origin and do not have the capacity to infiltrate, invade or metastasize to distant sites as malignant tumors do. They usually develop a rim of compressed connective tissue sometimes called a fibrous capsule.

The growth of cancers is accompanied by infiltration, invasion,

and destruction of theo surrounding tissuesinvasiveness is the most reliable feature that differentiates malignant from benign tumorso (e.g. blood vessel invasion)!! in situ carcinoma display the cytologic features of malignancy without invasion of thebasement membrane (mechanical barrier, used as a marker) !!

➔ metastasis: tumor implants discontinuous with the primary tumormetastasis unequivocally marks a tumor as a malignant because benign neoplasms do noto metastasizewith few exceptions, all cancers can metastasize:o 1. gliomas2. basal cell carcinoma of the skin (rodent ulcer due to its invasive destructiveness)→ only has capacity to have trophism to tissue belonging to the skin (attracted toperipheral nerves termination and bones)malignant cells secrete proteolytic enzymes able to degrade thebasement membranes, e.g. metalloproteinases able to digest basalmembrane around vessels→cancer cell going through vessel wall into the bloodstream possibility to have thrombi

(neoplastic thrombus into the vessels, possible to completely occlude vessels to give thrombosis, secondary to tumors→able to metastasize) able to make distant metastases ➢ seeding of body cavities and surfaces (pleura, pericardial, subarachnoid and joint space) ➢ lymphatic spread = most common pathway for the initial dissemination of carcinomas; pattern of lymph node involvement follows the natural routes of drainage→lymph node reactive hyperplasia drainage of tumor cell debris or tumor antigens or both ➢ hematogenous spread = typical of sarcomas →veins (thin walls) are more easily penetrated than arteries venous thrombosis fromo metastatic tumors neoplastic emboli follow the venous flow (= follow blood flow) draining the site ofo →neoplasm vena cava-lung; portal vein-liver; paravertebral plexus-vertebral metastases grading (level of differentiation) and staging (extent of spread of a cancer within the patient) are parameters→of the clinical gravity of the

disease grade I to IV with increasing anaplasia➔ G1 = maintaining of the architectural organization of cell pattern organization➔ G2 = anomalous architectural organization even if it is possible to recognize a normal organization(e.g. adenocarcinoma)➔ G3 = together with architectural pattern typical of original tissue we also have proliferation of single cells in the stroma indicating that we have the beginning in the loss of intercellular junctions➔ G4 = complete loss of architectural organization and only aggregates of neoplastic undifferentiated cells

grading of a cancer is based on the degree of differentiation of the tumor cells and number of mitoses within the tumor as presumes correlates of the neoplasm aggressiveness

correlation between histological appearance and biological behavior is less than perfect: in general, grading of cancer has proved of less clinical value than has staging

uterine adenocarcinoma

grade I grade II grade III

staging is based on the size of the primary lesion,

its extend of spread to regional lymphnodes and the presence or absence of blood borne metastases

TNM (UICC)

0-IV (AJC)

CNS tumors

2016 WHO classification of CNS tumors

  1. neuroepithelial tumor
  2. peripheral nerve tumor
  3. meningeal tumor not neuroepithelial tumors, they are CNS tumors but are not represented in the cerebral mass, deriving from different cells originating not from the neuroepithelium
  4. hematopoietic tumor and lymphomas
  5. germ cell tumor
  6. sellar tumor
  7. metastatic tumor

even if there is an hematoencephalic barrier, making a sort of mechanical barrier between the brain and the body, it is possible to have metastases originating from other organs in the body (e.g. colon metastases)

CNS tumors have not the possibility to go outside of the brain because there are 2 main problems

  1. presence of hematoencephalic barrier, therefore neoplastic cells are not able to pass through the blood vessels of the barrier to go out of the brain
  2. they are limited in a "box"
made of bones of the skull. Neuroepithelial tumors do not have a specific therapy and are particular tumors, mainly benign from the histological point of view but they are malignant from the biological point of view. One of the main important features of these tumors is that they are not metastasizing tumors, so they are not so malignant because the possibility to make metastasis is the main feature of malignant tumors. These tumors can be, from the histological point of view, both benign and malignant but they can be also malignant from the
Dettagli
Publisher
A.A. 2022-2023
127 pagine
SSD Scienze mediche MED/08 Anatomia patologica

I contenuti di questa pagina costituiscono rielaborazioni personali del Publisher neenarchive di informazioni apprese con la frequenza delle lezioni di Anatomia patologica e studio autonomo di eventuali libri di riferimento in preparazione dell'esame finale o della tesi. Non devono intendersi come materiale ufficiale dell'università Università degli Studi di Bologna o del prof Cenacchi Giovanna.